{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:48:33Z","timestamp":1780469313047,"version":"3.54.1"},"reference-count":120,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008953","name":"Prometheus Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>With the management of inflammatory bowel disease (IBD) becoming increasingly complex, incorporating preventive care health maintenance measures can be challenging. The aim of developing these updated recommendations is to provide more specific details to facilitate their use into a busy clinical practice setting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>Fifteen statements were formulated with recommendations regarding the target, timing, and frequency of the health maintenance interventions in patients with IBD. We used a modified Delphi method and a literature review to establish a consensus among the panel of experts. The appropriateness of each health maintenance statement was rated on a scale of 1 to 5 (1\u20132 as inappropriate, and 4\u20135 as appropriate) by each panelist. Interventions were considered appropriate, and statements were accepted if \u226580% of the panelists agreed with a score \u22654.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The panel approved 15 health maintenance recommendations for adults with IBD based on the current literature and expert opinion. These recommendations include explicit details regarding specific screening tools, timing of screening, and vaccinations for adults with IBD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients with IBD are at an increased risk for infections, malignancies, and other comorbidities. Given the complexity of caring for patients with IBD, this focused list of recommendations can be easily incorporated in to clinical care to help eliminate the gap in preventative care for patients with IBD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izab155","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T12:38:55Z","timestamp":1626698335000},"page":"1552-1563","source":"Crossref","is-referenced-by-count":13,"title":["Health Maintenance Consensus for Adults With Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"27","author":[{"given":"Gaurav","family":"Syal","sequence":"first","affiliation":[{"name":"Cedars-Sinai Medical Center , Los Angeles, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariastella","family":"Serrano","sequence":"additional","affiliation":[{"name":"MedStar Georgetown University Hospital , Washington DC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Animesh","family":"Jain","sequence":"additional","affiliation":[{"name":"University of North Carolina , Chapel Hill, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L","family":"Cohen","sequence":"additional","affiliation":[{"name":"Cleveland Clinic , Cleveland, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Rieder","sequence":"additional","affiliation":[{"name":"Cleveland Clinic , Cleveland, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stone","sequence":"additional","affiliation":[{"name":"Comprehensive Digestive Institute of Nevada , Las Vegas, Nevada , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bincy","family":"Abraham","sequence":"additional","affiliation":[{"name":"Houston Methodist Hospital , Houston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hudesman","sequence":"additional","affiliation":[{"name":"New York University Langone Medical Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Malter","sequence":"additional","affiliation":[{"name":"NYU Grossman School of Medicine, Bellevue Hospital Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McCabe","sequence":"additional","affiliation":[{"name":"MNGI Digestive Health , Plymouth, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2549-9042","authenticated-orcid":false,"given":"Stefan","family":"Holubar","sequence":"additional","affiliation":[{"name":"Cleveland Clinic , Cleveland, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Afzali","sequence":"additional","affiliation":[{"name":"Ohio State University Wexner Medical Center , Columbus, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S","family":"Cheifetz","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill K J","family":"Gaidos","sequence":"additional","affiliation":[{"name":"Yale University , New Haven, Connecticut , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0179-5477","authenticated-orcid":false,"given":"Alan C","family":"Moss","sequence":"additional","affiliation":[{"name":"Boston University School of Medicine , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"2022092120222311900_CIT0001","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.15585\/mmwr.mm6542a3","article-title":"Prevalence of inflammatory bowel disease among adults aged \u226518 years - United States, 2015","volume":"65","author":"Dahlhamer","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2022092120222311900_CIT0002","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.gtc.2012.01.006","article-title":"Health maintenance in the inflammatory bowel disease patient","volume":"41","author":"Sinclair","year":"2012","journal-title":"Gastroenterol Clin North Am."},{"key":"2022092120222311900_CIT0003","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/ibd\/izy143","article-title":"Influences and impact of anxiety and depression in the setting of inflammatory bowel disease","volume":"24","author":"Navabi","year":"2018","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0004","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.dld.2017.08.020","article-title":"Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability","volume":"49","author":"Chan","year":"2017","journal-title":"Dig Liver Dis."},{"key":"2022092120222311900_CIT0005","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/apt.12440","article-title":"Smoking does influence disease behaviour and impacts the need for therapy in Crohn\u2019s disease in the biologic era","volume":"38","author":"Nunes","year":"2013","journal-title":"Aliment Pharmacol Ther."},{"key":"2022092120222311900_CIT0006","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1002\/ibd.21667","article-title":"Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge","volume":"17","author":"Wasan","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0007","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10620-010-1329-8","article-title":"Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients?","volume":"56","author":"Selby","year":"2011","journal-title":"Dig Dis Sci."},{"key":"2022092120222311900_CIT0008","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG clinical guideline: preventive care in inflammatory bowel disease","volume":"112","author":"Farraye","year":"2017","journal-title":"Am J Gastroenterol."},{"key":"2022092120222311900_CIT0009","volume-title":"Crohn\u2019s and Colitis Foundation Health Maintenance checklist for adults"},{"key":"2022092120222311900_CIT0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/ecco-jcc\/jjv064","article-title":"Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake","volume":"9","author":"Malhi","year":"2015","journal-title":"J Crohns Colitis."},{"key":"2022092120222311900_CIT0011","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.cgh.2019.03.037","article-title":"Appropriate therapeutic drug monitoring of biologic agents for patients with inflammatory bowel diseases","volume":"17","author":"Papamichael","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0012","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"2022092120222311900_CIT0013","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ibd\/izy243","article-title":"Increased risk of influenza and influenza-related complications among 140,480 patients with inflammatory bowel disease","volume":"25","author":"Tinsley","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0014","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol."},{"key":"2022092120222311900_CIT0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.MIB.0000437737.68841.87","article-title":"Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement","volume":"20","author":"Wasan","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0016","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2011.11.109","article-title":"Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review","volume":"30","author":"Agarwal","year":"2012","journal-title":"Vaccine."},{"key":"2022092120222311900_CIT0017","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MIB.0000000000000615","article-title":"Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial","volume":"22","author":"deBruyn","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0018","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.crohns.2012.05.011","article-title":"Immune response to influenza A\/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-\u03b1 agents: effects of combined therapy with immunosuppressants","volume":"7","author":"Andrisani","year":"2013","journal-title":"J Crohns Colitis."},{"key":"2022092120222311900_CIT0019","first-page":"593","article-title":"Immunogenicity of high dose influenza vaccine for patients with inflammatory bowel disease on anti-TNF monotherapy: a randomized clinical trial","volume":"26","author":"Caldera","year":"2020","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0020","first-page":"595","article-title":"Immunogenicity of the currently recommended pneumococcal vaccination schedule in patients with inflammatory bowel disease","volume":"70","author":"van Aalst","year":"2020","journal-title":"Clin Infect Dis."},{"key":"2022092120222311900_CIT0021","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ibd.21800","article-title":"Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study","volume":"18","author":"Fiorino","year":"2012","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0022","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis."},{"key":"2022092120222311900_CIT0023","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpeds.2015.12.072","article-title":"Hospitalization for Varicella and Zoster in children with inflammatory bowel disease","volume":"171","author":"Adams","year":"2016","journal-title":"J Pediatr."},{"key":"2022092120222311900_CIT0024","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MPG.0b013e31821e1917","article-title":"Varicella immunity in inflammatory bowel disease","volume":"53","author":"Ansari","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2022092120222311900_CIT0025","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ibd.23027","article-title":"Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD","volume":"19","author":"Naganuma","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0026","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2036.2012.05150.x","article-title":"Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines","volume":"36","author":"Kopylov","year":"2012","journal-title":"Aliment Pharmacol Ther."},{"key":"2022092120222311900_CIT0027","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcv.2013.01.015","article-title":"Varicella immunity in vaccinated healthcare workers","volume":"57","author":"Behrman","year":"2013","journal-title":"J Clin Virol."},{"key":"2022092120222311900_CIT0028","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep."},{"key":"2022092120222311900_CIT0029","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MPG.0b013e3181bab351","article-title":"Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy","volume":"50","author":"Lu","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2022092120222311900_CIT0030","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/acr.20183","article-title":"Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids","volume":"62","author":"Pileggi","year":"2010","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"2022092120222311900_CIT0031","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis."},{"key":"2022092120222311900_CIT0032","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.cgh.2006.09.019","article-title":"Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease","volume":"4","author":"Gupta","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0033","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/apt.12182","article-title":"Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease","volume":"37","author":"Long","year":"2013","journal-title":"Aliment Pharmacol Ther."},{"key":"2022092120222311900_CIT0034","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.cgh.2017.12.052","article-title":"Overall and comparative risk of herpes zoster with pharmacotherapy for inflammatory bowel diseases: a nationwide cohort study","volume":"16","author":"Khan","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0035","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/ibd\/izy131","article-title":"Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib","volume":"24","author":"Winthrop","year":"2018","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0036","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.cgh.2018.10.016","article-title":"Efficacy of live attenuated herpes zoster vaccine in patients with inflammatory bowel diseases","volume":"17","author":"Khan","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0037"},{"key":"2022092120222311900_CIT0038"},{"key":"2022092120222311900_CIT0039","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/ibd\/izz264","article-title":"Vaccinations and immunization status in pediatric inflammatory bowel disease: a multicenter study from the pediatric IBD Porto Group of the ESPGHAN","volume":"26","author":"Martinelli","year":"2020","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0040","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/ibd\/izy366","article-title":"Serologic status of routine childhood vaccines, cytomegalovirus, and epstein-barr virus in children with inflammatory bowel disease","volume":"25","author":"deBruyn","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0041","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1007\/s10620-016-4275-2","article-title":"Many inflammatory bowel disease patients are not immune to measles or pertussis","volume":"61","author":"Cleveland","year":"2016","journal-title":"Dig Dis Sci."},{"key":"2022092120222311900_CIT0042","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.vaccine.2017.01.048","article-title":"Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - a systematic review of randomized trials, observational studies and case reports","volume":"35","author":"Croce","year":"2017","journal-title":"Vaccine."},{"key":"2022092120222311900_CIT0043","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ajg.2016.21","article-title":"Safety and efficacy of live measles vaccine administered to a Crohn\u2019s disease patient receiving vedolizumab","volume":"111","author":"Wichmann","year":"2016","journal-title":"Am J Gastroenterol."},{"key":"2022092120222311900_CIT0044","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10620-018-5321-z","article-title":"Immunosuppression does not affect antibody concentrations to measles, mumps, and rubella in patients with inflammatory bowel disease","volume":"64","author":"Caldera","year":"2019","journal-title":"Dig Dis Sci."},{"key":"2022092120222311900_CIT0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol."},{"key":"2022092120222311900_CIT0046","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"G\u00f3mez-Reino","year":"2003","journal-title":"Arthritis Rheum."},{"key":"2022092120222311900_CIT0047","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum."},{"key":"2022092120222311900_CIT0048","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/ard.2005.043166","article-title":"Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis","volume":"65","author":"Schiff","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"2022092120222311900_CIT0049","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","article-title":"Genetic dissection of immunity to mycobacteria: the human model","volume":"20","author":"Casanova","year":"2002","journal-title":"Annu Rev Immunol."},{"key":"2022092120222311900_CIT0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.14794","article-title":"Long-term efficacy and safety of ustekinumab for Crohn\u2019s disease through the second year of therapy","volume":"48","author":"Sandborn","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"key":"2022092120222311900_CIT0051","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2133.2012.11162.x","article-title":"A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial","volume":"168","author":"Tsai","year":"2013","journal-title":"Br J Dermatol."},{"key":"2022092120222311900_CIT0052","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jdcr.2017.02.001","article-title":"Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis","volume":"3","author":"Lynch","year":"2017","journal-title":"JAAD Case Rep."},{"key":"2022092120222311900_CIT0053","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/rheumatology\/keu172","article-title":"Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies","volume":"53","author":"Souto","year":"2014","journal-title":"Rheumatology (Oxford)."},{"key":"2022092120222311900_CIT0054","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13075-019-1866-2","article-title":"Safety and efficacy of tofacitinib for up to 9.5\u2009years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study","volume":"21","author":"Wollenhaupt","year":"2019","journal-title":"Arthritis Res Ther."},{"key":"2022092120222311900_CIT0055","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med."},{"key":"2022092120222311900_CIT0056","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.crohns.2012.05.012","article-title":"Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening","volume":"7","author":"Jauregui-Amezaga","year":"2013","journal-title":"J Crohns Colitis."},{"key":"2022092120222311900_CIT0057","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/ecco-jcc\/jjy057","article-title":"A prospective study to monitor for tuberculosis during anti-tumour necrosis factor therapy in patients with inflammatory bowel disease and immune-mediated inflammatory diseases","volume":"12","author":"Lee","year":"2018","journal-title":"J Crohns Colitis."},{"key":"2022092120222311900_CIT0058","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1572-0241.2008.02050.x","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease","volume":"103","author":"Schoepfer","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"2022092120222311900_CIT0059","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/ard.2007.069799","article-title":"Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy","volume":"66","author":"Sellam","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"2022092120222311900_CIT0060","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1097\/MIB.0000000000000147","article-title":"Performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients","volume":"20","author":"Wong","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0061","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cgh.2017.11.038","article-title":"Factors that contribute to indeterminate results from the QuantiFERON-TB gold in-tube test in patients with inflammatory bowel disease","volume":"16","author":"Kaur","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0062","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/apt.12651","article-title":"Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis","volume":"39","author":"Casta\u00f1o-Milla","year":"2014","journal-title":"Aliment Pharmacol Ther."},{"key":"2022092120222311900_CIT0063","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2013.03.044","article-title":"Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease","volume":"145","author":"Beaugerie","year":"2013","journal-title":"Gastroenterology."},{"key":"2022092120222311900_CIT0064","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1053\/j.gastro.2006.03.028","article-title":"Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study","volume":"130","author":"Velayos","year":"2006","journal-title":"Gastroenterology."},{"key":"2022092120222311900_CIT0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc."},{"key":"2022092120222311900_CIT0066","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.cgh.2013.06.023","article-title":"Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study","volume":"11","author":"Rubin","year":"2013","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0067","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cgh.2010.09.020","article-title":"Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis","volume":"9","author":"Thackeray","year":"2011","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0068","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cgh.2016.11.025","article-title":"Incidence, risk factors, and outcomes of colorectal cancer in patients with ulcerative colitis with low-grade dysplasia: a systematic review and meta-analysis","volume":"15","author":"Fumery","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0069","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/s41395-018-0354-7","article-title":"Strategies for detecting colorectal cancer in patients with inflammatory bowel disease: a cochrane systematic review and meta-analysis","volume":"113","author":"Bye","year":"2018","journal-title":"Am J Gastroenterol."},{"key":"2022092120222311900_CIT0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol."},{"key":"2022092120222311900_CIT0071","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ogc.2013.02.005","article-title":"Cervical cancer screening in immunocompromised women","volume":"40","author":"Nguyen","year":"2013","journal-title":"Obstet Gynecol Clin North Am."},{"key":"2022092120222311900_CIT0072","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study","volume":"108","author":"Jess","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"2022092120222311900_CIT0073","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","article-title":"Higher incidence of abnormal Pap smears in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"2022092120222311900_CIT0074","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cgh.2014.07.036","article-title":"Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study","volume":"13","author":"Rungoe","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0075","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/MIB.0000000000000338","article-title":"Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia\/cancer? A meta-analysis","volume":"21","author":"Allegretti","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0076","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cgh.2008.10.007","article-title":"Suboptimal rates of cervical testing among women with inflammatory bowel disease","volume":"7","author":"Long","year":"2009","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0077","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ibd.21567","article-title":"Screening for cervical and breast cancer among women with inflammatory bowel disease: a population-based study","volume":"17","author":"Singh","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0078","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/COC.0000000000000264","article-title":"Impact of widespread cervical cancer screening: number of cancers prevented and changes in race-specific incidence","volume":"41","author":"Yang","year":"2018","journal-title":"Am J Clin Oncol."},{"key":"2022092120222311900_CIT0079","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000001263","article-title":"Practice Bulletin No. 157: Cervical Cancer Screening and Prevention","volume":"127","year":"2016","journal-title":"Obstet Gynecol."},{"key":"2022092120222311900_CIT0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cgh.2013.04.033","article-title":"Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis","volume":"12","author":"Singh","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0081","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology."},{"key":"2022092120222311900_CIT0082","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ajg.2013.451","article-title":"Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis","volume":"109","author":"Ariyaratnam","year":"2014","journal-title":"Am J Gastroenterol."},{"key":"2022092120222311900_CIT0083","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet."},{"key":"2022092120222311900_CIT0084","volume-title":"Skin Cancer Screening, National Cancer Institute"},{"key":"2022092120222311900_CIT0085","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1097\/01.MIB.0000435850.17263.13","article-title":"Cost-effectiveness of nonmelanoma skin cancer screening in Crohn\u2019s disease patients","volume":"19","author":"Okafor","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0086","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1007\/s10620-018-5141-1","article-title":"Cost-effectiveness of melanoma screening in inflammatory bowel disease","volume":"63","author":"Anderson","year":"2018","journal-title":"Dig Dis Sci."},{"key":"2022092120222311900_CIT0087","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/2050640616658224","article-title":"Prediction of low bone mineral density in patients with inflammatory bowel diseases","volume":"4","author":"Sch\u00fcle","year":"2016","journal-title":"United European Gastroenterol J."},{"key":"2022092120222311900_CIT0088","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjmed.2009.01.022","article-title":"Osteoporosis in inflammatory bowel disease","volume":"122","author":"Ali","year":"2009","journal-title":"Am J Med."},{"key":"2022092120222311900_CIT0089","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.crohns.2008.03.002","article-title":"High prevalence of low bone mineral density in patients with Inflammatory Bowel Disease in the setting of a peripheral Dutch hospital","volume":"2","author":"Van Schaik","year":"2008","journal-title":"J Crohns Colitis."},{"key":"2022092120222311900_CIT0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/gut.40.2.228","article-title":"Reduced bone density in patients with inflammatory bowel disease","volume":"40","author":"Bjarnason","year":"1997","journal-title":"Gut."},{"key":"2022092120222311900_CIT0091","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1572-0241.1998.468_q.x","article-title":"Femoral neck osteopenia in patients with inflammatory bowel disease","volume":"93","author":"Pollak","year":"1998","journal-title":"Am J Gastroenterol."},{"key":"2022092120222311900_CIT0092","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.2003.026799","article-title":"Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study","volume":"53","author":"Card","year":"2004","journal-title":"Gut."},{"key":"2022092120222311900_CIT0093","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","article-title":"The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study","volume":"133","author":"Bernstein","year":"2000","journal-title":"Ann Intern Med."},{"key":"2022092120222311900_CIT0094","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cgh.2012.10.022","article-title":"Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis","volume":"11","author":"Targownik","year":"2013","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0095","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s00198-018-4586-6","article-title":"Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis","volume":"29","author":"Szafors","year":"2018","journal-title":"Osteoporos Int."},{"key":"2022092120222311900_CIT0096","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","article-title":"Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial","volume":"391","author":"Shepstone","year":"2018","journal-title":"Lancet."},{"key":"2022092120222311900_CIT0097","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement","volume":"319","author":"Curry","year":"2018","journal-title":"JAMA."},{"key":"2022092120222311900_CIT0098","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa1107142","article-title":"Bone-density testing interval and transition to osteoporosis in older women","volume":"366","author":"Gourlay","year":"2012","journal-title":"N Engl J Med."},{"key":"2022092120222311900_CIT0099","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/MIB.0000000000000620","article-title":"Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases","volume":"22","author":"Mikocka-Walus","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0100","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00054725-200608000-00005","article-title":"Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys","volume":"12","author":"Fuller-Thomson","year":"2006","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0101","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1097\/MIB.0000000000000537","article-title":"Risk Factors for Rehospitalization Within 90 Days in Patients with Inflammatory Bowel Disease","volume":"21","author":"Allegretti","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0102","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/apt.12195","article-title":"Psychiatric co-morbidity is associated with increased risk of surgery in Crohn\u2019s disease","volume":"37","author":"Ananthakrishnan","year":"2013","journal-title":"Aliment Pharmacol Ther."},{"key":"2022092120222311900_CIT0103","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/ibd\/izy068","article-title":"The validity and reliability of screening measures for depression and anxiety disorders in inflammatory bowel disease","volume":"24","author":"Bernstein","year":"2018","journal-title":"Inflamm Bowel Dis."},{"key":"2022092120222311900_CIT0104","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S2468-1253(16)30206-0","article-title":"Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis","volume":"2","author":"Gracie","year":"2017","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0105","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1037\/ccp0000227","article-title":"Effectiveness of cognitive-behavioral therapy on quality of life, anxiety, and depressive symptoms among patients with inflammatory bowel disease: a multicenter randomized controlled trial","volume":"85","author":"Bennebroek Evertsz\u2019","year":"2017","journal-title":"J Consult Clin Psychol."},{"key":"2022092120222311900_CIT0106","doi-asserted-by":"crossref","first-page":"2047242","DOI":"10.1155\/2018\/2047242","article-title":"The effect of antidepressants on the course of inflammatory bowel disease","volume":"2018","author":"Hall","year":"2018","journal-title":"Can J Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0107","first-page":"CD012680","article-title":"Adjuvant therapy with antidepressants for the management of inflammatory bowel disease","volume":"4","author":"Mikocka-Walus","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"2022092120222311900_CIT0108","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1046\/j.1365-2036.1999.00630.x","article-title":"Effects of current and former cigarette smoking on the clinical course of Crohn\u2019s disease","volume":"13","author":"Cosnes","year":"1999","journal-title":"Aliment Pharmacol Ther."},{"key":"2022092120222311900_CIT0109","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s41395-018-0273-7","article-title":"Smoking status at diagnosis and subsequent smoking cessation: associations with corticosteroid use and intestinal resection in Crohn\u2019s disease","volume":"113","author":"Alexakis","year":"2018","journal-title":"Am J Gastroenterol."},{"key":"2022092120222311900_CIT0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ecco-jcc\/jjv238","article-title":"Smoking is associated with extra-intestinal manifestations in inflammatory bowel disease","volume":"10","author":"Severs","year":"2016","journal-title":"J Crohns Colitis."},{"key":"2022092120222311900_CIT0111","first-page":"342","article-title":"Smoking is associated with higher disease-related costs and lower health-related quality of life in inflammatory bowel disease","volume":"11","author":"Severs","year":"2017","journal-title":"J Crohns Colitis."},{"key":"2022092120222311900_CIT0112","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1365-2168.2000.01443.x","article-title":"Smoking and disease recurrence after operation for Crohn\u2019s disease","volume":"87","author":"Yamamoto","year":"2000","journal-title":"Br J Surg."},{"key":"2022092120222311900_CIT0113","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fimmu.2018.00074","article-title":"Impact of cigarette smoking on the gastrointestinal tract inflammation: opposing effects in Crohn\u2019s disease and ulcerative colitis","volume":"9","author":"Berkowitz","year":"2018","journal-title":"Front Immunol."},{"key":"2022092120222311900_CIT0114","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4065\/81.11.1462","article-title":"Smoking and inflammatory bowel disease: a meta-analysis","volume":"81","author":"Mahid","year":"2006","journal-title":"Mayo Clin Proc."},{"key":"2022092120222311900_CIT0115","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/BF01536701","article-title":"A meta-analysis of the role of smoking in inflammatory bowel disease","volume":"34","author":"Calkins","year":"1989","journal-title":"Dig Dis Sci."},{"key":"2022092120222311900_CIT0116","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/apt.15390","article-title":"The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population-based study","volume":"50","author":"Blackwell","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"key":"2022092120222311900_CIT0117","doi-asserted-by":"crossref","first-page":"e000309","DOI":"10.1136\/bmjgast-2019-000309","article-title":"Current smoking habits in British IBD patients in the age of e-cigarettes","volume":"6","author":"Chong","year":"2019","journal-title":"BMJ Open Gastroenterol."},{"key":"2022092120222311900_CIT0118","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MEG.0000000000001010","article-title":"Practices, attitudes, and knowledge about Crohn\u2019s disease and smoking cessation among gastroenterologists","volume":"30","author":"Nulsen","year":"2018","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"2022092120222311900_CIT0119","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.crohns.2012.08.019","article-title":"Smoking and Crohn\u2019s disease: active modification of an independent risk factor (education alone is not enough)","volume":"7","author":"Kennelly","year":"2013","journal-title":"J Crohns Colitis."},{"key":"2022092120222311900_CIT0120","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1053\/gast.2001.23231","article-title":"Smoking cessation and the course of Crohn\u2019s disease: an intervention study","volume":"120","author":"Cosnes","year":"2001","journal-title":"Gastroenterology."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/27\/10\/1552\/45955366\/izab155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/27\/10\/1552\/45955366\/izab155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T20:24:24Z","timestamp":1663791864000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/27\/10\/1552\/6323888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":120,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,7,19]]},"published-print":{"date-parts":[[2021,10,18]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izab155","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,7,19]]}}}